This summary was created by AI, based on 1 opinions in the last 12 months.
Treatment.com AI, with the symbol TRUE-CN, has garnered positive reviews from experts for its use of AI to make medical processes more efficient. The company's medical language model, which operates within a finite universe of medical data, has the potential to assist doctors, receptionists, dispatchers, and nursing centers in diagnosing issues. Treatment.com AI is currently debt-free and has secured a significant deal with the University of Edinburgh. The experts believe that additional deals could propel the company to become cashflow positive in the near future.
Treatment.com AI is a Canadian stock, trading under the symbol TRUE-CN on the Canadian Securities Exchange (). It is usually referred to as or TRUE-CN
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
Treatment.com AI was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Treatment.com AI.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
On 2024-12-11, Treatment.com AI (TRUE-CN) stock closed at a price of $0.63.
Using AI to make things more efficient. Medical language model, using a finite universe of only medical data. Helps doctors to diagnose issues. Can be used by medical office receptionists, doctors, 911 dispatchers, nursing centres. Debt free. Deal signed with University of Edinburgh. A few more deals should make them cashflow positive.